{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:24:57Z","timestamp":1794605097813,"version":"4.9.1"},"reference-count":125,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The fibroblast activation protein (FAP) is a biomarker that is selectively overexpressed on cancer-associated fibroblasts (CAFs) in various types of tumoral tissues and some nonmalignant diseases, including fibrosis, arthritis, cardiovascular, and metabolic diseases. FAP plays a critical role in tumor microenvironment through facilitating proliferation, invasion, angiogenesis, immunosuppression, and drug resistance. Recent studies reveal that FAP might be regarded as a promising target for cancer diagnosis and treatment. FAP-targeted imaging modalities, especially PET, have shown high sensitivity and specificity in detecting FAP-expressing tumors. FAP-targeted imaging can potentially enhance tumor detection, staging, and monitoring of treatment response, and facilitate the development of personalized treatment strategies. This study provides a comprehensive view of FAP and its function in the pathophysiology of cancer and nonmalignant diseases. It also will discuss the characteristics of radiolabeled FAP inhibitors, particularly those based on small molecules, their recent clinical implications in imaging and therapy, and the associated clinical challenges with them. In addition, we present the results of imaging and biodistribution radiotracer\n                    <jats:sup>68<\/jats:sup>\n                    Ga-FAPI-46 in patients with nonmalignant diseases, including interstitial lung disease, primary biliary cirrhosis, and myocardial infarction, who were referred to our department. Our results show that cardiac FAP-targeted imaging can provide a novel potential biomarker for managing left ventricle remodeling. Moreover, this study has been organized and presented in a manner that offers a comprehensive overview of the current status and prospects of FAPI inhibitors in the diagnosis and treatment of diseases.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000005348","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T21:00:08Z","timestamp":1721336408000},"page":"e538-e556","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":44,"title":["Recent Clinical Implications of FAPI"],"prefix":"10.1097","volume":"49","author":[{"given":"Mahshid","family":"Kiani","sequence":"first","affiliation":[{"name":"Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safura","family":"Jokar","sequence":"additional","affiliation":[{"name":"Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Hassanzadeh","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, School of Medicine, Rajaie Cardiovascular, Medical & Research Center, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Behnammanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Bavi","sequence":"additional","affiliation":[{"name":"Department of Mechanical Engineering, Shiraz University of Technology, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Beiki","sequence":"additional","affiliation":[{"name":"Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Assadi","sequence":"additional","affiliation":[{"name":"The Persian Gulf Nuclear Medicine Research Center, Department of Molecular Imaging and Radionuclide Therapy, Bushehr Medical University Hospital, Bushehr University of Medical Sciences, Bushehr, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","article-title":"The role of fibroblast activation protein in health and malignancy","volume":"39","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"bib2-20250621","first-page":"43","article-title":"Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs","volume":"4","year":"2013","journal-title":"FEBS open bio"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"19441","DOI":"10.1074\/jbc.C500092200","article-title":"Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha","volume":"280","year":"2005","journal-title":"J Biol Chem"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2005-08-3452","article-title":"Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein","volume":"107","year":"2006","journal-title":"Blood"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","article-title":"Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics","volume":"37","year":"2018","journal-title":"Oncogene"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1367-5931(03)00084-X","article-title":"Prolyl peptidases: a serine protease subfamily with high potential for drug discovery","volume":"7","year":"2003","journal-title":"Curr Opin Chem Biol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1074\/jbc.272.12.7595","article-title":"Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease","volume":"272","year":"1997","journal-title":"J Biol Chem"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1742-4658.2011.08051.x","article-title":"Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-\u03b1","volume":"278","year":"2011","journal-title":"FEBS J"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1007\/s00259-021-05307-1","article-title":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET\/CT in cancer patients","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/B978-0-12-394308-8.00003-0","article-title":"Fibroblast activation protein-\u03b1: a key modulator of the microenvironment in multiple pathologies","volume":"297","year":"2012","journal-title":"Int Rev Cell Mol Biol"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1038\/sj.onc.1207730","article-title":"FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor","volume":"23","year":"2004","journal-title":"Oncogene"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/hep.510290631","article-title":"Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis","volume":"29","year":"1999","journal-title":"Hepatology"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.diabres.2015.02.024","article-title":"Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity","volume":"108","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s10529-015-1855-8","article-title":"Luciferase expression is driven by the promoter of fibroblast activation protein-\u03b1 in murine pulmonary fibrosis","volume":"37","year":"2015","journal-title":"Biotechnol Lett"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2017.05.022","article-title":"Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis","volume":"809","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/ibd.21446","article-title":"Fibroblast activation protein expression in Crohn\u2019s disease strictures","volume":"17","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00403-010-1084-x","article-title":"Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option","volume":"302","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/ar1877","article-title":"Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis","volume":"8","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"R171","DOI":"10.1186\/ar2080","article-title":"Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes","volume":"8","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/eurheartj\/ehq519","article-title":"Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata","volume":"32","year":"2011","journal-title":"Eur Heart J"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1016\/j.ijcard.2013.06.061","article-title":"Circulating concentrations of fibroblast activation protein \u03b1 in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA","volume":"168","year":"2013","journal-title":"Int J Cardiol"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2017.01.037","article-title":"Changes in concentrations of circulating fibroblast activation protein alpha are associated with myocardial damage in patients with acute ST-elevation MI","volume":"232","year":"2017","journal-title":"Int J Cardiol"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1042\/BJ20151085","article-title":"Circulating FGF21 proteolytic processing mediated by fibroblast activation protein","volume":"473","year":"2016","journal-title":"Biochem J"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2967\/jnumed.120.259192","article-title":"Feasibility, biodistribution, and preliminary dosimetry in peptide-targeted radionuclide therapy of diverse adenocarcinomas using 177Lu-FAP-2286: first-in-humans results","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"15609","DOI":"10.1038\/s41598-020-72743-8","article-title":"A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts","volume":"10","year":"2020","journal-title":"Sci Rep"},{"key":"bib26-20250621","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/mt.2013.110","article-title":"Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma","volume":"21","year":"2013","journal-title":"Mol Ther"},{"key":"bib27-20250621","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.molmet.2016.07.003","article-title":"Fibroblast activation protein (FAP) as a novel metabolic target","volume":"5","year":"2016","journal-title":"Mol Metab"},{"key":"bib28-20250621","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.molmet.2018.10.011","article-title":"Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice","volume":"19","year":"2019","journal-title":"Mol Metab"},{"key":"bib29-20250621","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4161\/cbt.6.11.4874","article-title":"Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer","volume":"6","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"bib30-20250621","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1021\/jm1002556","article-title":"Substituted 4-carboxymethylpyroglutamic acid diamides as potent and selective inhibitors of fibroblast activation protein","volume":"53","year":"2010","journal-title":"J Med Chem"},{"key":"bib31-20250621","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1016\/j.bmcl.2012.03.107","article-title":"Acylated Gly-(2-cyano) pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP\/prolyl oligopeptidase (PREP)-selectivity","volume":"22","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"bib32-20250621","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1021\/jm400351a","article-title":"Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase","volume":"56","year":"2013","journal-title":"J Med Chem"},{"key":"bib33-20250621","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/ml300410d","article-title":"Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold","volume":"4","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"bib34-20250621","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1021\/jm500031w","article-title":"Extended structure\u2013activity relationship and pharmacokinetic investigation of (4-quinolinoyl) glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP)","volume":"57","year":"2014","journal-title":"J Med Chem"},{"key":"bib35-20250621","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A tumor-imaging method targeting cancer-associated fibroblasts","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib36-20250621","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2967\/jnumed.119.233122","article-title":"Theranostics targeting fibroblast activation protein in the tumor stroma: 64Cu-and 225Ac-labeled FAPI-04 in pancreatic cancer xenograft mouse models","volume":"61","year":"2020","journal-title":"J Nucl Med"},{"key":"bib37-20250621","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"68Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib38-20250621","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib39-20250621","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","article-title":"Development of fibroblast activation protein\u2013targeted radiotracers with improved tumor retention","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib40-20250621","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2967\/jnumed.119.239731","article-title":"Design and development of 99mTc-labeled FAPI tracers for SPECT imaging and 188Re therapy","volume":"61","year":"2020","journal-title":"J Nucl Med"},{"key":"bib41-20250621","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2967\/jnumed.120.245084","article-title":"FAPI-74 PET\/CT using either 18F-AlF or cold-kit 68Ga labeling: biodistribution, radiation dosimetry, and tumor delineation in lung cancer patients","volume":"62","year":"2021","journal-title":"J Nucl Med"},{"key":"bib42-20250621","first-page":"727","article-title":"Initial clinical experience with 90Y-FAPI-46 radioligand therapy for advanced-stage solid tumors: a case series of 9 patients","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib43-20250621","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00259-020-05132-y","article-title":"Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET\/CT in patients with various cancers","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib44-20250621","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2967\/jnumed.121.263016","article-title":"Synthesis, preclinical evaluation, and a pilot clinical PET imaging study of 68Ga-labeled FAPI dimer","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib45-20250621","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.yjmcc.2015.08.016","article-title":"Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction","volume":"87","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"bib46-20250621","first-page":"1","article-title":"Targeting of activated fibroblasts for imaging and therapy","volume":"4","year":"2019","journal-title":"EJNMMI Radiopharm Chem"},{"key":"bib47-20250621","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2741\/4682","article-title":"Targeting fibroblast activation protein in cancer\u2014prospects and caveats","volume":"23","year":"2018","journal-title":"Front Biosci (Landmark Ed)"},{"key":"bib48-20250621","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2967\/jnumed.119.237016","article-title":"The role of 68Ga-FAPI PET\/CT for patients with malignancies of the lower gastrointestinal tract: first clinical experience","volume":"61","year":"2020","journal-title":"J Nucl Med"},{"key":"bib49-20250621","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2967\/jnumed.121.262831","article-title":"Head-to-head comparison of 68Ga-FAPI-46 and 18F-FDG PET\/CT for evaluation of head and neck squamous cell carcinoma: a single-center exploratory study","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib50-20250621","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2967\/jnumed.120.258467","article-title":"68Ga-DOTA-FAPI-04 PET\/MR in the evaluation of gastric carcinomas: comparison with 18F-FDG PET\/CT","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib51-20250621","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1097\/RLU.0000000000003218","article-title":"Incidental detection of elastofibroma dorsi with 68Ga-FAPI-46 and 18F-FDG PET\/CT in a patient with esophageal cancer","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib52-20250621","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00259-021-05203-8","article-title":"Physiological FAP-activation in a postpartum woman observed in oncological FAPI-PET\/CT","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib53-20250621","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2967\/jnumed.121.261925","article-title":"Fibroblast activation protein\u2013specific PET\/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib54-20250621","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2967\/jnumed.121.262790","article-title":"The added value of 68Ga-FAPI PET\/CT in patients with head and neck cancer of unknown primary with 18F-FDG\u2013negative findings","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib55-20250621","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2967\/jnumed.121.262134","article-title":"Detecting fibroblast activation proteins in lymphoma using 68Ga-FAPI PET\/CT","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib56-20250621","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2967\/jnumed.121.262426","article-title":"Correlation of 68Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: interim analysis of a prospective translational exploratory study","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib57-20250621","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s11307-022-01749-7","article-title":"Head-to-head comparison of [68Ga] Ga-FAPI-46-PET\/CT and [18F] F-FDG-PET\/CT for radiotherapy planning in head and neck cancer","volume":"24","year":"2022","journal-title":"Mol Imaging Biol"},{"key":"bib58-20250621","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s00259-022-06068-1","article-title":"The role of [99mTc] Tc-HFAPi SPECT\/CT in patients with malignancies of digestive system: first clinical experience","volume":"50","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib59-20250621","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1007\/s00259-021-05194-6","article-title":"Non-malignant findings of focal 68Ga-FAPI-04 uptake in pancreas","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib60-20250621","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2967\/jnumed.122.265383","article-title":"Clinical evaluation of 68Ga-FAPI-RGD for imaging of fibroblast activation protein and integrin \u03b1v\u03b23 in various cancer types","volume":"64","year":"2023","journal-title":"J Nucl Med"},{"key":"bib61-20250621","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3390\/ph14121212","article-title":"First-in-human results on the biodistribution, pharmacokinetics, and dosimetry of [177Lu]Lu-DOTA.SA.FAPi and [177Lu]Lu-DOTAGA.(SA.FAPi)2","volume":"14","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"bib62-20250621","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1007\/s00259-021-05422-z","article-title":"Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity\u2014initial experience and comparison to [18F] FDG PET\/CT and MRI","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib63-20250621","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s00259-021-05266-7","article-title":"Equivalent tumor detection for early and late FAPI-46 PET acquisition","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib64-20250621","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1007\/s00259-020-04859-y","article-title":"Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib65-20250621","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1007\/s00259-019-04346-z","article-title":"FAPI-PET\/CT improves staging in a lung cancer patient with cerebral metastasis","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib66-20250621","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2967\/jnumed.120.253062","article-title":"Impact of 68Ga-FAPI PET\/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas","volume":"62","year":"2021","journal-title":"J Nucl Med"},{"key":"bib67-20250621","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1007\/s00259-020-04818-7","article-title":"[68Ga] Ga-DOTA-FAPI-04 improves tumor staging and monitors early response to chemoradiotherapy in a patient with esophageal cancer","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib68-20250621","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2021.04.016","article-title":"68Ga-FAPI-PET\/CT improves diagnostic staging and radiotherapy planning of adenoid cystic carcinomas\u2013imaging analysis and histological validation","volume":"160","year":"2021","journal-title":"Radiother Oncol"},{"key":"bib69-20250621","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2967\/jnumed.121.262096","article-title":"68Ga-FAPI as a diagnostic tool in sarcoma: data from the 68Ga-FAPI PET prospective observational trial","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib70-20250621","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s41181-021-00144-x","article-title":"18F-labeled tracers targeting fibroblast activation protein","volume":"6","year":"2021","journal-title":"EJNMMI Radiopharm Chem"},{"key":"bib71-20250621","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1097\/RLU.0000000000003678","article-title":"Theranostic approach in breast cancer: a treasured tailor for future oncology","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib72-20250621","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1097\/RLU.0000000000003810","article-title":"Feasibility and therapeutic potential of 177Lu-fibroblast activation protein inhibitor-46 for patients with relapsed or refractory cancers: a preliminary study","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib73-20250621","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/S2665-9913(21)00004-7","article-title":"Molecular imaging for systemic sclerosis-interstitial lung disease","volume":"3","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"bib74-20250621","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","article-title":"Systemic sclerosis-associated interstitial lung disease","volume":"8","year":"2020","journal-title":"Lancet Respir Med"},{"key":"bib75-20250621","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2665-9913(20)30421-5","article-title":"68Ga-FAPI-04 PET\/CT for molecular assessment of fibroblast activation and risk stratification in systemic sclerosis-related interstitial lung disease","volume":"3","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"supplement 1","key":"bib76-20250621","first-page":"298","article-title":"Fibroblast activation protein\u2013specific PET\/CT imaging in idiopathic pulmonary fibrosis with lung cancer","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib77-20250621","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/eurheartj\/ehq519","article-title":"Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata","volume":"32","year":"2011","journal-title":"Eur Heart J"},{"key":"bib78-20250621","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/annrheumdis-2020-217408","article-title":"Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging","volume":"79","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"bib79-20250621","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2967\/jnumed.120.244723","article-title":"Fibroblast activation protein\u2013targeted PET\/CT with 68Ga-FAPI for imaging IgG4-related disease: comparison to 18F-FDG PET\/CT","volume":"62","year":"2021","journal-title":"J Nucl Med"},{"key":"bib80-20250621","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/RLU.0000000000002919","article-title":"Recurrent immunoglobulin G4-related disease shown on 18F-FDG and 68Ga-FAPI PET\/CT","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib81-20250621","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.3390\/cancers13194946","article-title":"FAP and FAPI-PET\/CT in malignant and non-malignant diseases: a perfect symbiosis?","volume":"13","year":"2021","journal-title":"Cancers (Basel)"},{"key":"bib82-20250621","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00259-020-05129-7","article-title":"Active uptake of (68)Ga-FAPI in Crohn\u2019s disease but not in ulcerative colitis","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib83-20250621","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2967\/jnumed.119.226993","article-title":"Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labeled fibroblast activation protein inhibitor, FAPI-04","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib84-20250621","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s00259-020-05028-x","article-title":"[(68)Ga]Ga-DOTA-FAPI-04 PET\/CT imaging in a case of prostate cancer with shoulder arthritis","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib85-20250621","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/RLU.0000000000003608","article-title":"Inflammatory arthritis induced by anti-programmed death-1 shown in 68Ga-FAPI PET\/CT in a patient with esophageal carcinoma","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib86-20250621","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacbts.2019.02.006","article-title":"Fibroblasts in the infarcted, remodeling, and failing heart","volume":"4","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"bib87-20250621","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2009.199","article-title":"Myocardial remodeling after infarction: the role of myofibroblasts","volume":"7","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"bib89-20250621","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.molmed.2015.12.006","article-title":"The living scar\u2013cardiac fibroblasts and the injured heart","volume":"22","year":"2016","journal-title":"Trends Mol Med"},{"key":"bib90-20250621","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","article-title":"Cardiac fibrosis in myocardial infarction\u2014from repair and remodeling to regeneration","volume":"365","year":"2016","journal-title":"Cell Tissue Res"},{"key":"bib91-20250621","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jchf.2017.09.015","article-title":"Post-myocardial infarction heart failure","volume":"6","year":"2018","journal-title":"JACC Heart Fail"},{"key":"bib92-20250621","doi-asserted-by":"crossref","first-page":"e010628","DOI":"10.1161\/CIRCIMAGING.120.010628","article-title":"Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease","volume":"13","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"bib93-20250621","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s12350-020-02307-w","article-title":"Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury\/remodeling","volume":"28","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"bib94-20250621","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s12350-020-02407-7","article-title":"68Ga-FAPI right heart uptake in a patient with idiopathic pulmonary arterial hypertension","volume":"29","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"bib95-20250621","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1007\/s12350-021-02646-2","article-title":"Diffuse uptake of [68Ga] Ga-FAPI in the left heart in a patient with hypertensive heart disease by PET\/CT","volume":"29","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"bib96-20250621","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1007\/s12350-021-02603-z","article-title":"Imaging of cardiac fibroblast activation in a patient after acute myocardial infarction using 68Ga-FAPI-04","volume":"29","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"bib97-20250621","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/RLU.0000000000003745","article-title":"Visualization of fibroblast activation after myocardial infarction using 68Ga-FAPI PET","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib98-20250621","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"bib99-20250621","first-page":"30","article-title":"Curing lymphoma, breaking the heart\u2013multimodality imaging for valvular heart disease secondary to mediastinal irradiation","year":"2020","journal-title":"Rom J Cardiol"},{"key":"bib100-20250621","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"27","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"bib101-20250621","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10741-020-09952-w","article-title":"Cardiac imaging in cardiotoxicity: a focus on clinical practice","volume":"26","year":"2021","journal-title":"Heart Fail Rev"},{"key":"bib102-20250621","first-page":"1165","article-title":"Adverse events associated with immune checkpoint blockade","volume":"378","year":"2018","journal-title":"N Engl J Med"},{"key":"bib103-20250621","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"4","year":"2018","journal-title":"JAMA Oncol"},{"key":"bib104-20250621","doi-asserted-by":"crossref","first-page":"614997","DOI":"10.3389\/fcvm.2021.614997","article-title":"Early detection of checkpoint inhibitor-induced myocarditis using 68Ga-FAPI PET\/CT","volume":"8","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"bib105-20250621","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41824-021-00106-1","article-title":"68Ga-FAPI-04 PET\/MR is helpful in differential diagnosis of pancreatitis from pancreatic malignancy compared to 18F-FDG PET\/CT: a case report","volume":"5","year":"2021","journal-title":"Eur J Hybrid Imaging"},{"key":"bib106-20250621","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s00259-019-04478-2","article-title":"IgG4-related disease revealed by 68Ga-FAPI and 18F-FDG PET\/CT","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib107-20250621","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/RLU.0000000000004619","article-title":"Prominent 68Ga-FAPI uptake in renal parenchyma caused by immunoglobulin G4\u2013related nephropathy","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib108-20250621","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1097\/RLU.0000000000003015","article-title":"68Ga-FAPI PET\/CT in assessment of liver nodules in a cirrhotic patient","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib109-20250621","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00259-020-04941-5","article-title":"[18F] FDG and [68Ga] Ga-DOTA-FAPI-04 PET\/CT in the evaluation of tuberculous lesions","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib110-20250621","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/RLU.0000000000003917","article-title":"68Ga-FAPI and 18F-PET\/CT images in intestinal tuberculosis","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib111-20250621","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1007\/s00259-022-05720-0","article-title":"A case of [68Ga] Ga-FAPI-46-avid and [18F] F-FDG-negative COVID-19 pneumonia sequelae","volume":"49","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib112-20250621","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1097\/RLU.0000000000003854","article-title":"18F-FDG PET\/CT and 68Ga-FAPI-4 PET\/CT findings of bilateral knee osteoarthritis in a patient with uveal malignant melanoma","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib113-20250621","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/RLU.0000000000003957","article-title":"Increased 68Ga-FAPI uptake in facet joint osteoarthritis in a patient with esophageal cancer","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib114-20250621","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/RLU.0000000000003798","article-title":"Increased 68Ga-FAPI uptake in ankylosing spondylitis in a patient with rectal cancer","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib115-20250621","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/RLU.0000000000003671","article-title":"Fibrous dysplasia mimicking skeletal metastasis on 68Ga-FAPI PET imaging","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib116-20250621","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/RLU.0000000000003990","article-title":"Bone tuberculous granulomatous inflammation mimicking malignancy on 68Ga-FAPI PET\/CT","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib117-20250621","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/RLU.0000000000003491","article-title":"68Ga-DOTA-FAPI-04 PET\/CT in Erdheim-Chester disease","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib118-20250621","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1007\/s00259-021-05343-x","article-title":"Value of [68Ga] Ga-FAPI-04 imaging in the diagnosis of renal fibrosis","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib119-20250621","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1007\/s00259-021-05660-1","article-title":"[68Ga] Ga-FAPI uptake correlates with the state of chronic kidney disease","volume":"49","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib120-20250621","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2021.02.019","article-title":"Molecular imaging identifies fibroblast activation beyond the infarct region after acute myocardial infarction","volume":"77","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"bib121-20250621","doi-asserted-by":"crossref","first-page":"614997","DOI":"10.3389\/fcvm.2021.614997","article-title":"Early detection of checkpoint inhibitor-associated myocarditis using 68Ga-FAPI PET\/CT","volume":"8","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"bib122-20250621","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3390\/diagnostics12081958","article-title":"FAPI PET versus FDG PET, CT or MRI for staging pancreatic-, gastric- and cholangiocarcinoma: systematic review and head-to-head comparisons of diagnostic performances","volume":"12","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"bib123-20250621","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00259-023-06144-0","article-title":"Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre) clinical studies","volume":"50","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib124-20250621","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2967\/jnumed.123.265599","article-title":"Development of FAPI tetramers to improve tumor uptake and efficacy of FAPI radioligand therapy","volume":"64","year":"2023","journal-title":"J Nucl Med"},{"key":"bib125-20250621","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2967\/jnumed.121.262533","article-title":"Albumin binder\u2013conjugated fibroblast activation protein inhibitor radiopharmaceuticals for cancer therapy","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib126-20250621","article-title":"177Lu-DOTA-EB-FAPI imaging and therapy of fibroblast activation protein (FAP) positive tumors","year":"2022","journal-title":"Soc Nuclear Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T15:07:59Z","timestamp":1750518479000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005348"}},"subtitle":["Imaging and Therapy"],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":125,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005348","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,17]]}}}